Memantine for spasticity in multiple sclerosis patients

Trial Profile

Memantine for spasticity in multiple sclerosis patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2015

At a glance

  • Drugs Memantine (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Feb 2010 Results published in Multiple Sclerosis.
    • 07 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top